Why Is Cadrenal Therapeutics Stock Drawing Retail Attention Today? The company said VLX-1005 targets a high-risk heparin complication with limited treatment options.
CVKD Stock Earnings: Cadrenal Therapeutics Misses EPS for Q2 2024 CVKD stock results show that Cadrenal Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
CVKD Stock Earnings: Cadrenal Therapeutics Misses EPS for Q1 2024 CVKD stock results show that Cadrenal Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday We're starting off Thursday with a breakdown of all the biggest pre-market stock movers traders will want to keep an eye on this morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday Pre-market stock movers are the perfect way to start the week as we dive into the biggest stories moving shares on Monday!
Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket Shares of 4D Molecular Therapeutics, Inc. (
NASDAQ: FDMT ) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability & clinical activity in wet AMD.
Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session Shares of Skechers U.S.A., Inc. (
NYSE: SKX ) shares fell during Friday’s session after the company reported mixed fourth-quarter financial results.
